BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34174264)

  • 1. Apelin/APJ system: A novel therapeutic target for locomotor system diseases.
    Luo J; Liu W; Feng F; Chen L
    Eur J Pharmacol; 2021 Sep; 906():174286. PubMed ID: 34174264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apelin/APJ system: an emerging therapeutic target for respiratory diseases.
    Yan J; Wang A; Cao J; Chen L
    Cell Mol Life Sci; 2020 Aug; 77(15):2919-2930. PubMed ID: 32128601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apelin/APJ system as a therapeutic target in diabetes and its complications.
    Hu H; He L; Li L; Chen L
    Mol Genet Metab; 2016 Sep; 119(1-2):20-7. PubMed ID: 27650065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The apelin/APJ system as a therapeutic target in metabolic diseases.
    Castan-Laurell I; Masri B; Valet P
    Expert Opin Ther Targets; 2019 Mar; 23(3):215-225. PubMed ID: 30570369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel pathogenesis: regulation of apoptosis by Apelin/APJ system.
    Liu J; Liu M; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):471-478. PubMed ID: 28407045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apelin/APJ system: A novel promising target for anti-aging intervention.
    Zhou Q; Chen L; Tang M; Guo Y; Li L
    Clin Chim Acta; 2018 Dec; 487():233-240. PubMed ID: 30296443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apelin/APJ system: A potential therapeutic target for endothelial dysfunction-related diseases.
    Cheng J; Luo X; Huang Z; Chen L
    J Cell Physiol; 2019 Aug; 234(8):12149-12160. PubMed ID: 30585633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Apelinergic System in Cardiometabolic Disease.
    Guo R; Rogers O; Nair S
    Curr Drug Targets; 2017; 18(15):1785-1791. PubMed ID: 27296311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apelin/APJ system: A bifunctional target for cardiac hypertrophy.
    Lu L; Wu D; Li L; Chen L
    Int J Cardiol; 2017 Mar; 230():164-170. PubMed ID: 27979574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin/APJ system: an emerging therapeutic target for neurological diseases.
    Li A; Zhao Q; Chen L; Li Z
    Mol Biol Rep; 2023 Feb; 50(2):1639-1653. PubMed ID: 36378421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apelin/Apelin Receptor System: Molecular Characteristics, Physiological Roles, and Prospects as a Target for Disease Prevention and Pharmacotherapy.
    Kinjo T; Higashi H; Uno K; Kuramoto N
    Curr Mol Pharmacol; 2021; 14(2):210-219. PubMed ID: 32484774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis.
    Chen L; Zhou T; White T; O'Brien A; Chakraborty S; Liangpunsakul S; Yang Z; Kennedy L; Saxena R; Wu C; Meng F; Huang Q; Francis H; Alpini G; Glaser S
    Hepatology; 2021 Jun; 73(6):2411-2428. PubMed ID: 32964473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apelin/APJ system in the regulation of vascular tone: friend or foe?
    Rikitake Y
    J Biochem; 2021 Apr; 169(4):383-386. PubMed ID: 33169143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Apelin/APJ axis in cancer development and progression.
    Masoumi J; Jafarzadeh A; Khorramdelazad H; Abbasloui M; Abdolalizadeh J; Jamali N
    Adv Med Sci; 2020 Mar; 65(1):202-213. PubMed ID: 32087570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apelin/APJ system: A critical regulator of vascular smooth muscle cell.
    Luo X; Liu J; Zhou H; Chen L
    J Cell Physiol; 2018 Jul; 233(7):5180-5188. PubMed ID: 29215755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
    Kuba K; Sato T; Imai Y; Yamaguchi T
    Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The G protein-coupled receptor ligand apelin-13 ameliorates skeletal muscle atrophy induced by chronic kidney disease.
    Enoki Y; Nagai T; Hamamura Y; Osa S; Nakamura H; Taguchi K; Watanabe H; Maruyama T; Matsumoto K
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):553-564. PubMed ID: 36562292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
    Huang Z; He L; Chen Z; Chen L
    J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of apelin/APJ system in hypothalamic-pituitary axis.
    Yang N; Li T; Cheng J; Tuo Q; Shen J
    Clin Chim Acta; 2019 Dec; 499():149-153. PubMed ID: 31525345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apelin/APJ system: A novel promising therapy target for pathological angiogenesis.
    Wu L; Chen L; Li L
    Clin Chim Acta; 2017 Mar; 466():78-84. PubMed ID: 28025030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.